Partnership aims to improve cost-to-deliver, compress timelines, strengthen compliance, and enable faster, evidence-backed decision-making across the clinical development lifecycle Singapore, 09 April 2026 Expecto Health Science, a full-service Asia-Pacific Contract…
Expecto Health Science is pleased to be a part of the ISCR Conference 2026, one of the key gatherings for professionals and leaders in the clinical research industry. The conference…
Singapore, 19 February 2026 – Expecto Health Science, a Singapore-headquartered, Asia-focused clinical research organization (CRO), and Southern Star Research (SSR), a leading Australia-based CRO, today announced a strategic investment-driven partnership.…
The Expecto Health Science team attended the ASMA | Annual Summit on Medical Affairs 2025 in Singapore, engaging in insightful discussions on the future of Medical Affairs, AI and digital…
Expecto Health Science attended ESMO Asia 2025, gaining valuable insights into emerging oncology therapies and clinical research trends across the APAC region. The conference supported our ongoing commitment to advancing…
Expecto Health Science is pleased to announce that it has received the License to Operate as a Contract Research Organization (CRO) from the Philippines Food and Drug Administration (FDA). This…
We are pleased to share an important milestone for Expecto Health Science: achievement of First Patient In (FPI) in a global clinical study within five months of regulatory submission. This…
This collaboration brings together Ubuntu Research Inc’s deep expertise in translational science with Expecto Health Science robust capabilities in global clinical trial execution New Delhi: Expecto Health Science, a Singapore-based clinical…
Our 𝗖𝗵𝗶𝗲𝗳 𝗘𝘅𝗲𝗰𝘂𝘁𝗶𝘃𝗲 𝗢𝗳𝗳𝗶𝗰𝗲𝗿, Dr. Pramod and 𝗖𝗵𝗶𝗲𝗳 𝗕𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝗢𝗳𝗳𝗶𝗰𝗲𝗿, Simon W. had the pleasure of attending the scientific seminar organized by the 𝗜𝗻𝗱𝗼𝗻𝗲𝘀𝗶𝗮𝗻 𝗔𝘀𝘀𝗼𝗰𝗶𝗮𝘁𝗶𝗼𝗻 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗦𝘁𝘂𝗱𝘆 𝗼𝗳 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗮𝗹𝘀…
